A truncated lipoglycan from mycobacteria with altered immunological properties

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 6, 2010, Pages 2634-2639

  Birch, Helen L ^a   Alderwick, Luke J ^a   Appelmelk, Ben J ^b   Maaskant, Janneke ^b   Bhatt, Apoorva ^a   Singh, Albel ^a   Nigou, Jerome ^c   Eggeling, Lothar ^d   Geurtsen, Jeroen ^b   Besra, Gurdyal S ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^d FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

Arabinofuranosyltransferase; Cell wall; Ethambutol; Lipoarabinomannan; Mycobacterium tuberculosis

Indexed keywords

ARABINOFURANOSYLTRANSFERASE; BACTERIAL ENZYME; ETHAMBUTOL; INTERLEUKIN 8; LIPOARABINOMANNAN; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; DRUG MECHANISM; MYCOBACTERIUM SMEGMATIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ANTIGENS, BACTERIAL; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CELL LINE; CELL LINE, TUMOR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHAMBUTOL; HUMANS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MAGNETIC RESONANCE SPECTROSCOPY; MUTATION; MYCOBACTERIUM SMEGMATIS; PENTOSYLTRANSFERASES; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

CORYNEBACTERINEAE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 77249086620     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0915082107     Document Type: Article

References (43)

1. Dye C (2006) Global epidemiology of tuberculosis. Lancet 367:938-940.
2. Kaye K, Frieden TR (1996) Tuberculosis control: The relevance of classic principles in an era of acquired immunodeficiency syndrome and multidrug resistance. Epidemiol Rev 18:52-63.
3. Shah NS, et al. (2007) Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis 13:380-387.
4. McNeil M, Daffe M, Brennan PJ (1991) Location of the mycolyl ester substituents in the cell walls of mycobacteria. J Biol Chem 266:13217-13223.
5. Daffé M, McNeil M, Brennan PJ (1993) Major structural features of the cell wall arabinogalactans of Mycobacterium, Rhodococcus, and Nocardia spp. Carbohydr Res 249:383-398.
6. Besra GS, et al. (1995) A new interpretation of the structure of the mycolyl-arabinogalactan complex of Mycobacterium tuberculosis as revealed through characterization of oligoglyco sylalditol fragments by fast-atom bombardment mass spectrometry. Biochemistry 34: 4257-4266.
7. Telenti A, et al. (1997) The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 3:567-570.
8. Belanger AE, et al. (1996) The embAB genes of Mycobacterium avium encode an arabinosyltransferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc Nac Acad Sci USA 93(21):11919-11924.
9. Alderwick LJ, Seidel M, Sahm H, Besra GS, Eggeling L (2006) Identification of a novel arabinofuranosyltransferase (AftA) involved in cell wall arabinan biosynthesis in Mycobacterium tuberculosis. J Biol Chem 281:15653-15661.
10. Seidel M, et al. (2007) Identification of a novel arabinofuranosyltransferase AftB involved in a terminal step of cell wall arabinan biosynthesis in Corynebacterianeae, such as Corynebacterium glutamicum and Mycobacterium tuberculosis. J Biol Chem 282:14729-14740.
11. Birch HL, et al. (2008) Biosynthesis of mycobacterial arabinogalactan: Identification of a novel α(1->3) arabinofuranosyltransferase. Mol Microbiol 69:1191-1206.
12. Besra GS, Brennan PJ (1997) The mycobacterial cell wall: Biosynthesis of arabinogalactan and lipoarabinomannan. Biochem Soc Trans 25:845-850.
13. Morita YS, Patterson JH, Billman-Jacobe H, McConville MJ (2004) Biosynthesis of mycobacterial phosphatidylinositol mannosides. Biochem J 378:589-597.
14. Berg S, Kaur D, JacksonM, Brennan PJ (2007) The glycosyltransferases of Mycobacterium tuberculosis: Roles in the synthesis of arabinogalactan, lipoarabinomannan, and other glycoconjugates. Glycobiology 17:35-56R.
15. Józefowski S, Sobota A, Kwiatkowska K (2008) How Mycobacterium tuberculosis subverts host immune responses. Bioessays 30:943-954.
16. Khoo KH, Dell A, Morris HR, Brennan PJ, Chatterjee D (1995) Inositol phosphate capping of the nonreducing termini of lipoarabinomannan from rapidly growing strains of Mycobacterium. J Biol Chem 270:12380-12389.
17. Gilleron M, et al. (1997) Mycobacterium smegmatis phosphoinositols-glyceroarabinomannans. Structure and localization of alkali-labile and alkali-stable phosphoinositides. J Biol Chem 272:117-124.
18. Khoo KH, Tang JB, Chatterjee D (2001) Variation in mannose-capped terminal arabinan motifs of lipoarabinomannans from clinical isolates of Mycobacterium tuberculosis and Mycobacterium avium complex. J Biol Chem 276:3863-3871.
19. Nigou J, Gilleron M, Puzo G (1999) Lipoarabinomannans: Characterization of the multiacylated forms of the phosphatidyl-myo-inositol anchor by NMR spectroscopy. Biochem J 337:453-460.
20. Nigou J, et al. (1997) The phosphatidyl-myo-inositol anchor of the lipoarabinomannans from Mycobacterium bovis bacillus Calmette Guérin. Heterogeneity, structure, and role in the regulation of cytokine secretion. J Biol Chem 272:23094-23103.
21. Mikusová K, Slayden RA, Besra GS, Brennan PJ (1995) Biogenesis of the mycobacterial cell wall and the site of action of ethambutol. Antimicrob Agents Chemother 39: 2484-2489.
22. Zhang N, et al. (2003) The Emb proteins of mycobacteria direct arabinosylation of lipoarabinomannan and arabinogalactan via an N-terminal recognition region and a C-terminal synthetic region. Mol Microbiol 50:69-76.
23. Petzold CJ, Stanton LH, Leary JA (2005) Structural characterization of Lipoarabinomannans from Mycobacterium tuberculosis and Mycobacterium smegmatis by ESI mass spectrometry. J Am Soc Mass Spectrom 16:1109-1116.
24. Vignal C, et al. (2003) Lipomannans, but not lipoarabinomannans, purified from Mycobacterium chelonae and Mycobacterium kansasii induce TNF-alpha and IL-8 secretionbyaCD14-toll-like receptor2-dependentmechanism. J Immunol 171:2014-2023.
25. Quesniaux VJ, et al. (2004) Toll-like receptor 2 (TLR2)-dependent- positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J Immunol 172:4425-4434.
26. Nigou J, et al. (2008) Mannan chain length controls lipoglycans signaling via and binding to TLR2. J Immunol 180:6696-6702.
27. Doz E, et al. (2007) Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of proinflammatory cytokines by mycobacterial lipomannan. J Biol Chem 282:26014-26025.
28. Guerardel Y, et al. (2002) Structural study of lipomannan and lipoarabinomannan from Mycobacterium chelonae. Presence of unusual components with α 1,3-mannopyranose side chains. J Biol Chem 277:30635-30648.
29. Briken V, Porcelli SA, Besra GS, Kremer L (2004) Mycobacterial lipoarabinomannan and related lipoglycans: From biogenesis to modulation of the immune response. Mol Microbiol 53:391-403.
30. Morr M, Takeuchi O, Akira S, Simon MM, Mühlradt PF (2002) Differential recognition of structural details of bacterial lipopeptides by toll-like receptors. Eur J Immunol 32: 3337-3347.
31. Zähringer U, Lindner B, Inamura S, Heine H, Alexander C (2008) TLR2: Promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 213:205-224.
32. Feinberg H, Mitchell DA, Drickamer K, Weis WI (2001) Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 294:2163-2166.
33. Appelmelk BJ, et al. (2003) Cutting edge: Carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J Immunol 170:1635-1639.
34. Pitarque S, et al. (2005) Deciphering the molecular bases of Mycobacterium tuberculosis binding to the lectin DC-SIGN reveals an underestimated complexity. Biochem J 392:615-624.
35. Maeda N, et al. (2003) The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J Biol Chem 278:5513-5516.
36. Sassetti CM, Boyd DH, Rubin EJ (2003) Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 48:77-84.
37. Gilleron M, Nigou J, Nicolle D, Quesniaux V, Puzo G (2006) The acylation state of mycobacterial lipomannans modulates innate immunity response through toll-like receptor 2. Chem Biol 13:39-47.
38. Tapping RI, Tobias PS (2003) Mycobacterial lipoarabinomannan mediates physical interactions between TLR1 and TLR2 to induce signaling. J Endotoxin Res 9:264-268.
39. Underhill DM, Ozinsky A, Smith KD, Aderem A (1999) Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci USA 96:14459-14463.
40. Chatterjee D, Roberts AD, Lowell K, Brennan PJ, Orme IM (1992) Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect Immun 60:1249-1253.
41. Mishra AK, et al. (2008) Identification of a novel α(1→6) mannopyranosyltransferase MptB from Corynebacterium glutamicum by deletion of a conserved gene, NCgl1505, affords a lipomannan- and lipoarabinomannan-deficient mutant. Mol Microbiol 68: 1595-1613.
42. Mambula SS, Sau K, Henneke P, Golenbock DT, Levitz SM (2002) Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem 277:39320-39326.
43. van Die I, et al. (2003) The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x. Glycobiology 13:471-478.